The news directly pertains to Stericycle as RBC Capital has lowered its price target for the company. However, the Outperform rating is maintained, indicating that the analyst still expects the stock to do better than the market average. This could have a neutral impact on the stock's price in the short term as the lowered price target might be seen as a negative signal, but the maintained Outperform rating could offset this.